Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis.
about
Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosisZinc in Multiple Sclerosis: A Systematic Review and Meta-AnalysisNutrition facts in multiple sclerosisThe mechanism of action of interferon-β in relapsing multiple sclerosisComplementary and alternative medicine for the treatment of multiple sclerosisMatrix metalloproteinase-7 facilitates immune access to the CNS in experimental autoimmune encephalomyelitis.Binswanger's disease: toward a diagnosis agreement and therapeutic approachMatrix Metalloproteinase-Mediated Neuroinflammation in Vascular Cognitive Impairment of the Binswanger TypeMultimodal markers of inflammation in the subcortical ischemic vascular disease type of vascular cognitive impairment.Pathogenic implications of iron accumulation in multiple sclerosis.Inhibition of myelin-cleaving poteolytic activities by interferon-beta in rat astrocyte cultures. Comparative analysis between gelatinases and calpain-IIMatrix metalloproteinases are associated with increased blood-brain barrier opening in vascular cognitive impairmentValidation of biomarkers in subcortical ischaemic vascular disease of the Binswanger type: approach to targeted treatment trials.Consensus statement for diagnosis of subcortical small vessel disease.Matrix metalloproteinase-9 contributes to brain extravasation and edema in fulminant hepatic failure mice.Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis PatientsEfficacy of doxycycline as add-on to interferon beta-1a in treatment of multiple sclerosis.Elevation of matrix metalloproteinases 3 and 9 in cerebrospinal fluid and blood in patients with severe traumatic brain injuryHeterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants.Matrix metalloproteinases and their pathological upregulation in multiple sclerosis: an overview.The role of microglia and matrix metalloproteinases involvement in neuroinflammation and gliomasMatrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers.Binswanger's disease: biomarkers in the inflammatory form of vascular cognitive impairment and dementia.Lipoic acid in multiple sclerosis: a pilot study.ApoE-deficient promotes blood-brain barrier disruption in experimental autoimmune encephalomyelitis via alteration of MMP-9.Interferon-beta inhibits the expression of metalloproteinases in rat glial cell cultures: implications for multiple sclerosis pathogenesis and treatment.TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis.Extracellular matrix metalloproteinase inducer is associated with severity of brain oedema following experimental subarachnoid haemorrhage in rats.Imaging matrix metalloproteinase activity in multiple sclerosis as a specific marker of leukocyte penetration of the blood-brain barrier.Structure-dependent inhibition of gelatinases by dietary antioxidants in rat astrocytes and sera of multiple sclerosis patients.Matrix metalloproteinase 9 is decreased in natalizumab-treated multiple sclerosis patients at risk for progressive multifocal leukoencephalopathy.Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis.Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis.Biomarkers
P2860
Q21144285-53C8D2EE-4C85-4091-9E49-8C86C9A66BB6Q26747289-9EBF7D0E-E425-4AF2-B5B1-C12C5882B5B8Q26851247-C7351051-DF86-4D66-8F9D-F77DC564B568Q28239752-EE09DE53-E3FE-49BC-8E7E-BE72F27BC83AQ29031018-DF73D0FB-9FB3-4C17-8B5A-DBC6C2A40184Q30486651-A487B6A8-4CE2-4305-862C-4E55CE1B9A85Q30848732-97103915-E794-4A22-BE93-1A56634470D4Q31060741-70267A4C-1397-4E84-BF1F-5C4D5BDB0DBEQ33631080-72C48CA1-3159-4239-81E3-85E8AF2481F2Q34049616-9FBE9F73-796B-4F6B-8EFD-B027226ABB7CQ34579845-EDF73C95-108A-4179-9C9C-2105A30761B8Q35059041-50C967DD-30B1-455A-BD0B-E9C1DB100FF3Q35925235-F40F3E90-4EB4-47EA-8D23-A9124E149F3CQ36593206-728C1E8F-B646-469E-A75D-A2672E025FA7Q37155284-CE657E33-30C0-4B67-82F7-C37E7A13FD18Q37171985-AFD78A60-9ED8-4DB3-9CD9-DC4660A46C70Q37311605-006F1E54-5B57-4C3A-8B6D-2E305D008204Q37393237-B0102A68-4D04-4E32-9D65-132E7F989508Q37595298-794096FC-B7DE-4893-8EC7-FD28A2012B56Q38134015-15A7155D-C836-4B6A-8D89-5D309747CBAAQ38136195-5C7A30C5-9CD9-46A4-9823-68E38F14052CQ38870841-059F84FD-460D-4A9C-8985-5AD3B8FBFEDBQ45945707-A0F02B0C-415E-4887-B95D-B75AC181F86DQ46407394-57582F5F-67AA-4359-8969-F4AC75490D7FQ46762520-14CE54A5-D4FC-4327-8556-21CFA7757866Q47276298-1675F083-A76E-43D1-9D75-CAB2519AD99FQ48338849-BC0CDABB-6FE2-4D38-A101-CCBF8C62B9DEQ48404340-2FE2876E-3CCC-488F-8C2D-EDCA386F634AQ48434563-D6CE397D-5DDE-43E8-9A3C-C0F4C8E233EBQ50529367-43AD92E8-0097-453E-9F85-99260B36C1DDQ50543805-9C068090-1FC4-4EDB-8113-7261F09C3D50Q50773267-7C6B909C-085E-4AEF-8A16-49DB55A0B9A8Q52591499-80AA6789-30FE-4821-913C-71E211BDB72FQ57083573-6FBEAE18-E12B-4ACB-AB8A-4840A3B69A8A
P2860
Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Intrathecal synthesis of matri ...... implication for pathogenesis.
@en
Intrathecal synthesis of matri ...... implication for pathogenesis.
@nl
type
label
Intrathecal synthesis of matri ...... implication for pathogenesis.
@en
Intrathecal synthesis of matri ...... implication for pathogenesis.
@nl
prefLabel
Intrathecal synthesis of matri ...... implication for pathogenesis.
@en
Intrathecal synthesis of matri ...... implication for pathogenesis.
@nl
P2093
P2860
P50
P1476
Intrathecal synthesis of matri ...... implication for pathogenesis.
@en
P2093
P2860
P304
P356
10.1191/1352458502MS800OA
P577
2002-05-01T00:00:00Z